Will molnupiravir be a game changer in our efforts to safe COVID-19 outpatients?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 3, 2022
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- COVID-19 (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Cytidine (MeSH)
- Humans (MeSH)
- Hydroxylamines (MeSH)
- Outpatients (MeSH)
- SARS-CoV-2 (MeSH)